C-Greens Highlights New Study on Struggle Women With PCOS Face
Women With PCOS Often Feel Ignored and Dismissed by Health Care Providers.
As much as 13% of women of reproductive age have been diagnosed with PCOS. This can lead to a variety of side effects, including:
- Pelvic pain
- Acne and weight gain
- Irregular periods and infertility
- High testosterone levels
- Fatigue
- Hair loss or hirsutism
While this is an example of a variety of common concerns in women's health, many women struggle to find effective solutions to manage both symptoms and root causes. Pharmaceutical options are available in some cases, but often nutraceutical formulas can offer natural support for the body by providing key ingredients for biological processes, such as:
- Myo-inositol (600 mg): This helps to restore hormonal balance and improve ovulation regularity in women with PCOS.
- Folic acid (400 mcg): This supports reproductive health and reduces risk factors for pregnancy complications by aiding proper cell development.
- L-carnitine (1000 mg): This enhances energy metabolism in ovarian cells and improves egg quality, boosting fertility outcomes in PCOS.
"PCOS is more than a fertility issue," said Dr.
About California Greens
California Greens is an internationally based company operating in the nutraceutical market since 2009. It has expanded from there to build a portfolio that spans skin health, immunity, women's health, and metabolic support. The company operates with a mission to develop natural, clinically tested wellness solutions that address today's most common health concerns. It is committed to combining rigorous science with premium natural ingredients to create safe, effective solutions for consumers worldwide. Learn more at c-greens.com.
Media Contact:
California Greens
[email protected]
+1(732)266-0110
View original content:https://www.prnewswire.com/news-releases/c-greens-highlights-new-study-on-struggle-women-with-pcos-face-302575755.html
SOURCE California Greens
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- usecure launches uHealth, the defining product for Human Risk Intelligence
- Lynch Regenerative Medicine Announces Completion of Enrollment in a Phase II Clinical Trial Evaluating rhPDGF-BB in the Reconstruction of Full-Thickness Head or Neck Defects Following Skin Cancer Exci
- The Most Meaningful Christmas Gift of 2026: Have Your Life Story Turned Into a Book
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share